Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

CVS Health's Health Services segment posted Q2 2026 revenue of $51.8 billion, up 11.5% year-over-year, while adjusted operating income rose 10%. The Health Care Delivery unit drove growth with a 23% revenue jump fueled by Oak Street Health expansion. Pharmacy Services added $6 billion in new sales, supported by favorable drug mix dynamics.

CVS maintained its full-year 2026 guidance despite ongoing adjustments to the 340B drug discount program, a federal initiative that has pressured margin expectations across the sector. The company's ability to hold outlook signals management confidence in offsetting 340B headwinds through volume growth and care delivery scale.

The 11.5% top-line acceleration in Health Services contrasts with pressures facing managed care peers UNH and ELV, positioning CVS's integrated model as a potential relative winner if pharmacy benefit management and primary care integration continue to offset reimbursement pressures.